Inside the pharma industry’s lobbying campaign to water down reforms
Pharmaceutical companies are currently granted at least eight years’ “protection” over their data from research and clinical ...
Pharma firms ‘disappointed and concerned’ by lack of State support for campaign against EU reforms
Correspondence seen by The Irish Times shows several big pharma companies, such as Pfizer, MSD, Novo Nordisk and AstraZeneca, ...
Pharmaceutical Technology on MSN18h
Taiho outlays $1.14bn to acquire ADC specialist Araris
Taiho Pharmaceutical has agreed to acquire Swiss-based antibody-drug-conjugate (ADC) specialist Araris Biotech for up to ...
Le Lézard17h
Buyback of Class B shares in Essity during week 11, 2025 Buyback program completed
Between March 10, 2025, and , Essity Aktiebolag (publ) repurchased a total of 188,500 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of ...
Indiatimes21h
Nifty Pharma
What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...